Trial Profile
A study analysing the efficacy of daclatasvir and asunaprevir treatment for long-term follow up of liver function parameters and liver fibrosis markers in genotype 1b hepatitis C virus infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Therapeutic Use
- 14 Oct 2016 New trial record